Keystone Symposia | Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics
Vascular Biology and Human Diseases:
From Molecular Pathways to Novel Therapeutics
Organizers: Elisabetta Dejana, Anne C. Eichmann and Gavin O. Thurston
February 25—March 1, 2018
Eldorado Hotel & Spa • Santa Fe, New Mexico USA
Summary of the Meeting:
Recent years have seen rapid progress in our knowledge of how the vascular system is formed during embryo development and in adults expressing in proliferative diseases such as cancer. It has become unequivocally evident that endothelial cells express highly specific and distinct functions in arteries, veins and lymphatics. Moreover, endothelial cells are able to further modify their functional properties in order to meet the specific needs of the different organs. This conference addressed the mechanisms that orchestrate organ-specific endothelial differentiation, making a connection between endothelial dysfunction and organ pathology. The major challenge has been to link our experimental knowledge to the understanding of human vascular diseases. The symposium has brought together teams of vascular biologists, neuroscientists, immunologists and clinicians from all over the world to share their recent discoveries and to direct future efforts to find novel and more precise therapies.
The final program, including session and oral presentation titles and speakers, is available at the following link: Keystone Symposia | Scientific Conference on "Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics" - Scientific Program.
